发明名称 |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer |
摘要 |
The present invention provides a coating comprising a reservoir layer comprising a semi-crystalline polymer and a primer layer comprising an amorphous polymer on an implantable device and methods of making and using the same. |
申请公布号 |
US9592323(B2) |
申请公布日期 |
2017.03.14 |
申请号 |
US201314109795 |
申请日期 |
2013.12.17 |
申请人 |
Abbott Cardiovascular Systems Inc. |
发明人 |
Lim Florencia;Trollsas Mikael O.;Hossainy Syed F.A.;Pacetti Stephen D. |
分类号 |
A61L31/10;A61L31/16;A61L31/14 |
主分类号 |
A61L31/10 |
代理机构 |
Squire Patton Boggs (US) LLP |
代理人 |
Squire Patton Boggs (US) LLP |
主权项 |
1. An implantable device, comprising a coating comprising:
a reservoir layer comprising a biodegradable semi-crystalline polymer and a bioactive agent, and a primer comprising a biodegradable amorphous polymer; wherein the semi-crystalline polymer is selected from the group consisting of semi-crystalline poly(L-lactide-co-glycolide) (PLLA-GA) polymers with the content of L-lactide ranging from about 65 molar % to about 100 molar %, semi-crystalline poly(L-lactide-co-caprolactone) (PLLA-CL) (L-lactide/CL=75/25 by molar) polymer, semi-crystalline poly(L-lactide-co-caprolactone) (PLLA-CL) (L-lactide/CL=70/30 by molar) polymer, and combinations thereof; wherein the amorphous polymer has a miscibility of at least 5% in the semi-crystalline polymer; wherein the amorphous polymer comprises a polyester having a degradation rate faster than the semi-crystalline polymer; and wherein the coating has a degradation or absorption rate that within a period of 6 months after deployment of the implantable device, the coating has a mass loss of about 80% or more. |
地址 |
Santa Clara CA US |